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GENERAL CHARACTERISTICS OF THE WORK 
Relevance of the research. Infectious inflammatory diseases of the respiratory system, 
including nosocomial (or hospital-acquired) pneumonia, are still an acute problem for 
modern health care. They are the reason for most cases of hospitalization, and they often 
lead to fatal termination. As official statistics show, in the Russian Federation annually 
more than 1.5 million people suffer from pneumonia, more than 40.000 die from 
pneumonia annually, and most cases of fatal termination are men of the employable age 
(A.G. Chuchalin 2006, 2010; A.I. Sinopalnikov 2010, 2012; G.G. Onischenko,        
K.B. Ezhlova, Y.V. Dyomina et al., 2013). Respiratory diseases are especially 
dangerous in closed military bodies where morbidity rate is several times higher than in 
civilian population (S.D. Zhogolev, P.I. Ogarkov 2003). 
Along with traditional etiological pathogens causing respiratory diseases (such as 
Streptococcus pneumoniae, Haemophilus influenzae, flu viruses etc.) we come across 
atypical, hard-to-cultivate pathogens such as Mycoplasma pneumoniae, Chlamydophila 
pneumoniaе, Legionella pneumophila etc., and herpes viruses such as Сytomegalovirus 
(CMV), Herpes simplex I/II. Their role in the development of respiratory infections and 
the necessity of their indication and identification is reflected in new normative 
documents including Methodic guideline #3.1.2.3047-13 “Epidemiological Supervision 
of Community-Acquired Pneumonia (CAP),” Methodic guideline # 4.2.3115-13 
“Laboratory Diagnostics of CAP”, Sanitary Rules # 3.1.2.3116-13 “Prevention of 
CAPs”. As the immune status of the population is deteriorating, the etiological role of 
these pathogens is growing, causing the respiratory system pathologies                    
(L.A. Vishnyakova 2005, T.A. Karapetyan 2008). According to medical literature, they 
are responsible for up to 30 per cent of respiratory diseases cases, and the frequency of 
finding them in different nosologic forms considerably varies in different authors’ 
works (A.G. Chuchalin 2006; G.G. Onischenko et al., 2013, 2014; Y.V. Dyomina, 
2014; B.A. Cunha, 2010; H. Kurz, 2011; G. Lui, 2009). 
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One should note that the above mentioned “atypical” pathogens are not detected 
reliably enough by the traditional methods (such as bacteriological, immunological, 
serologic ones) due to the special requirements to the cultivation conditions, high 
antigenic variability, etc. This is why, even if time and funds are invested vastly, the 
etiological factor is not determined in 30 to 70 per cent of cases (A.G. Chuchalin 2008; 
V. Sao, 2010). This explains why the polymerase chain reaction (PCR), based on the 
amplification of specific fragments of microorganisms’ genome, is a valuable diagnostic 
tool that allows for revealing infectious agents in any kind of biological substratum and 
improves the diagnostics of both acute and chronic respiratory diseases. Usage of the 
PCR method in clinical practice has been approved and recommended in many 
normative acts such as Methodological Guidelines # 42.3115-13 “Laboratory 
Diagnostics of CAPs” and Sanitary Rules # 3.1.2.3116-13 “Prevention of CAPs”. It is 
important to stress that this method is known for fast response (100-1000 cells or 
virions), quick results (within 6-8 hours), precision specificity up to 100%              
(G.A. Shipulin 2014; R. Dumke, 2007).   
 
Degree of elaboration of the research topic. Both Russian and foreign 
researchers have done much to study and describe the role of hard-to-cultivate 
microorganisms such as C. pneumoniae, C. psittaci,  М. pneumoniae, L. рneumophila, 
CMV etc. in the development of respiratory diseases (A.I. Sinopalnikov 2006;            
I.S. Tartakovsky 2010; A.G. Chuchalin 2010; V.I. Shakhgildyan 2010, and B.A. Cunha, 
2010; H. Kurz, 2011; G. Lui, 2009, to name just a few). In the latest decades respiratory 
tract diseases have been diagnosed with the help of biomolecular methods, mostly 
different variants of PCR (S.B. Yatsishina 2008; K. Gullsby, 2008; M. Khanna, 2005; 
K. Loens, 2008 and others). PCR diagnosticums (diagnostic agents) have been created, 
certified and produced for detecting pathogens causing respiratory diseases. 
However, in the Russian Federation there has never been conducted an 
investigation of vast contingent of patients in dependence to their age and the form of 
the respiratory system pathology with a view to PCR-based detection of various forms 
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of hard-to-cultivate pathogens. Up to now there is no data as to the most informative 
substratum for such investigations. Usually different biological substrates are being 
analyzed such as samples of phlegm, throat smears, nasopharynx smears, 
bronchoalveolar lavage, pleural fluid, biopsy samples (M. Cho, 2012;  D.R. Murdoch, 
2003), which makes the result interpretation and the final diagnosis hard to fulfill. 
Incidence rate in respiratory diseases, a wide spectrum of traditional and 
“atypical” pathogens, genetic variability of pathogens call for a wide application of 
unified molecular genetic methods of investigation to laboratory practice for solving 
diagnostic, clinical and epidemiological problems. 
 
Goal and tasks of the investigation. The goal of this work is to optimize the 
method of detecting hard-to-cultivate pathogens causing respiratory diseases 
(Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, 
Legionella pneumophila, Moraxella catarrhalis) and herpes viruses and also to estimate 
the frequency of detecting them in dependence to the patients’ age and the nosologic 
form of the disease. 
According to the stated goal the following tasks were singled out. 
1. To determine the most informative biological substratum for the PCR-based 
detection of hard-to-cultivate pathogens causing inflammatory respiratory diseases. 
2. To create an effective and economically justified method of the PCR-based 
detection of scarce hard-to-cultivate pathogens causing respiratory diseases. 
3. To estimate the frequency of revealing M. pneumoniae, C. pneumoniae, C. 
psittaci, L. pneumophila, M.catarrhalis, Cytomegalovirus, Herpes simplex I/II in 
children of various age groups and in adults (organized and unorganized ones) suffering 
from different inflammatory respiratory diseases. 
4. To elaborate the optimal algorithm of molecular detection of M. pneumoniae, 
C. pneumoniae, C. psittaci, L. pneumophila, M. catarrhalis, Сytomegalovirus, Herpes 
simplex I/II in patients of different age groups suffering from inflammatory 
bronchopulmonary diseases. 
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Academic novelty. A method of PCR-based detection of scarce hard-to-cultivate 
microorganisms in different biological substrates taken from children and adults with 
bronchopulmonary pathology has been proposed for the first time (medical novelty 
patent # 2406088 issued on the 10
th
 of December, 2010, “Method of Detecting Scarce 
and Hard-to-Cultivate Pathogens Causing Inflammatory Respiratory Diseases 
(Сytomegalovirus, Chlamydophila pneumoniae, Chlamydophila psittaci, Legionella 
pneumophila, Moraxella catarrhalis) with the Help of PCR”). 
For the first time, a vast inspection of patients of different age groups with various 
bronchopulmonary infections has been carried out, with PCR-based analysis of their 
substrates for a wide spectrum of hard-to-cultivate bacterial and viral pathogens. 
New knowledge has been achieved as to the frequency of finding individual types of 
hard-to-cultivate microorganisms in children of different age groups and in adults with 
various nosologic forms of infectious respiratory diseases. 
A new medical technology has been developed, “Complex PCR Based Inspection 
of Patients with Infection-Allergic Respiratory Diseases” (license for using FS # 
2009/084 issued on the 21
st
 of April, 2009, the Ministry of Health and Social Security of 
the Russian Federation) that allows for reducing the cost price of investigation and 
raising the effectiveness of detecting infectious agents. 
 
Scientific and practical value of the work. New information has been gathered 
concerning the frequency of finding hard-to-cultivate microorganisms during 
bronchopulmonary diseases, which can help to investigate the aetiopathogenesis and the 
development of the infection process during respiratory diseases. 
It has been shown that the frequency of detecting hard-to-cultivate microorganisms, 
pathogens causing respiratory diseases, depends on the type of the pathogen, the 
contingent and the age of the people inspected, the nosologic form of the disease. 
The suggested method of PCR-based detection of hard-to-cultivate pathogens causing 
respiratory diseases allows for raising the effectiveness and the reliability of the 
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diagnostic investigation, shortening its duration and lowering the cost by 3.8 to 7.6 
times. 
It has been proved that the identification of the “atypical” microorganisms while 
supporting the process of treatment is conductive to efficient adjustment of antibacterial 
and immunomodulatory therapy, which allows for shortening the period of a patient’s 
hospitalization. 
The developed method of detecting hard-to-cultivate pathogens causing respiratory 
diseases, defended by patent # 2406088, has been instilled in the diagnostic work of 
several medical institutions of Nizhny Novgorod and Nizhny Novgorod region. 
The results of the investigation have been used in developing the medical 
technology “Complex PCR Based Inspection of Patients with Infection-Allergic 
Respiratory Diseases” (license for using FS # 2009/084 21st of April, 2009, the Ministry 
of Health and Social Security of the Russian Federation), Methodological Guidelines 
“PCR-Based Detection of Scarce Hard-to-Cultivate Pathogens Causing Inflammatory 
Respiratory Diseases” (Methodological guidelines 4.2.0060-12, 2012), Methodological 
Guidelines “Algorithm of Detecting a Wide Spectrum of Pathogens Causing 
Inflammatory Respiratory Diseases” (recommended for usage on the regional level by 
the letter from the Federal Directorate for Consumer Rights and Health Protection # 
01/8010-12-26, the 18
th
 of July, 2012).  
 
The theses submitted for defense. 
1. The technique of PCR-based detection of scarce hard-to-cultivate 
microorganisms, based on using the method of “double minipools”, allows for making a 
diagnostically and economically justified screening of patients with various types of 
respiratory pathology, for it lessens the cost and the duration of diagnostic investigation. 
2. The frequency of detecting hard-to-cultivate infection agents causing 
respiratory diseases is determined by the nosologic form of the respiratory disease, the 
contingent and the age of the investigated, the specific peculiarities of the pathogen. 
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3. Speaking of hard-to-cultivate microorganisms, the domineering pathogen in the 
etiological structure of the respiratory disease is M.pneumoniae for children, 
M.pneumoniae and C.pneumoniae for adults. 
 
Reliability and validity of the results of the investigation are proved by the 
sufficient volume of the analyzed groups sampling, an ample number of examinations 
carried out (samples of different clinical substrates from 1841 patients with 
bronchopulmonary pathology and 449 persons from screening groups; all in all, 31 843 
PCR-based investigations have been conducted), also by the usage of certified 
molecular-genetic, immunologic methods that are known for their fast response and 
specificity. 
 
Approbation of the work. The thesis was approved at the joint meeting of the 
Academic Council and Interlaboratory Scientific Seminar at the Federal Budget Science 
Institution “Nizhny Novgorod Scientific Research Institute of Epidemiology and 
Microbiology named after Academician I.N. Blokhina” (Record #8, the 30th of October, 
2014). 
The results of the work have been presented and discussed at the VII Russian 
Congress of Infectiologists “New Technologies in Diagnosing and Treating Infectious 
Diseases”, Nizhny Novgorod, 2006; at the Second All-Russian Forum “The Health of 
the Nation is the Ground for Russia’s Well-Being”, Moscow, 2006; the scientific 
conference dedicated to the 85
th
 anniversary of Academician of the Russian Academy of 
Science I.N. Blokhina, Nizhny Novgorod, 2006; the IV All-Russia academic and 
research conference “Molecular Diagnostics”, Moscow, 2007; the Jubilee All-Russia 
academic and research conference dedicated to the 90
th
 anniversary of the Nizhny 
Novgorod Scientific Research Institute of Epidemiology and Microbiology named after 
Academician I.N. Blokhina, Nizhny Novgorod, 2009; the academic and research 
conference for young scientists “Innovative Technologies in Antiepidemic Protection of 
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Population”, Nizhny Novgorod, 2011; the V Annual All-Russia Congress on Infectious 
Diseases, Moscow, 2013. 
 
Connection of the work with scientific programs and the author’s personal 
contribution to the investigation. The investigation was held within the framework of 
sectorial programs “Scientific Aspects of Securing Sanitary and Epidemiological Well-
Being in the Russian Federation for 2006-2010” (section of the research effort “Study of 
Distribution and the Peculiarities of Circulation of Atypical and Hard-to-Cultivate 
Pathogens Causing Inflammatory and Infection-Allergic Respiratory Diseases” (state 
registration number 01200612239)) and “Scientific Research and Projects to Ensure 
Sanitary and Epidemiological Well-Being and Reduction of Infections Rate in the 
Russian Federation” in 2011-2015 (requirements specification dated the 11th of January, 
2011, “Study of Persistence of Herpes Viruses (I, II, III, IV, V, VI, VII types) and 
Bacteria Mycoplasma in Children with the Help of Molecular-Genetic Methods. 
Working out the Algorithm of Monitoring Active Replication of Herpes Viruses in 
Children of Different Age Groups” (state registration number 01201175712)). One of 
the units of the work was developed within the limits of the Russian Ministry of 
Defense’s task “Study of the Peculiarities of the Epidemiology and Clinical Course of 
CAP in Military Personnel at the Present Stage” (2003-2007). 
The author’s personal contribution to the results stated in the thesis consists in 
performing molecular-genetic investigation, the theoretic generalization of the results, 
and the statistical treatment of the data. The competitor together with her co-authors has 
suggested a new medical technology (license for using the medical technology FS # 
2009/084), methodological guidelines 4.2.0060-12, methodological guidelines 
“Algorithm of Detecting a Wide Spectrum of Pathogens Causing Inflammatory 
Respiratory Diseases” (letter from the Federal Directorate for Consumer Rights and 
Health Protection # №01/8010-12-26 dated the 18th of July, 2012). The results the 
author has come up with are the basis for acquiring medical patent # 2406088. 
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Published papers. 16 papers were published based on the thesis, out of which: 5 
in the reviewed editions, 8 in collected conference and congress reports, 1 a medical 
patent, 1 a medical technology, 1 methodological guidelines. 
 
The volume and structure of the thesis. The thesis contains 132 pages of 
printed text and consists of an Introduction, the analysis of the sources, 6 chapters of 
independent research, Conclusion, practical recommendations, prospects and directions 
for further work, a list of the abbreviations used, and a reference list (bibliography). The 
thesis contains 13 illustrations and 8 tables. The reference list includes 200 references, 
out of which 20 are Russian and 180 are foreign publications. 
 
Thanks and regards. The author expresses her sincere gratitude to her scientific 
adviser, Professor E.I. Yefimov, Doctor of Medicine, for the attentive appraisal of the 
work, the fruitful discussion of the results and comprehensive help; and also to 
Associate Professor V.N. Mazepa, Doctor of Biology, under whose supervision the 
research which is the basis for this work was launched and carried out. In particular the 
author would like to thank Associate Professor N.F. Brusnigina, Candidate of Medical 
Science, the head of the laboratory of metagenomics and molecular indication of 
pathogens, for her priceless help in creating the thesis and for her support, and also all 
the researchers of the laboratory, for their help in performing the experiments. The 
author expresses her gratitude to Professor G.I. Grigorieva, Doctor of Biology, deputy 
director for scientific work of the Federal Budget Science Institution “Nizhny Novgorod 
Scientific Research Institute of Epidemiology and Microbiology named after 
Academician I.N. Blokhina”, for her valuable ideas; to I.S. Dobrotina, Candidate of 
Medical Science, Associate Professor of the Chair of Hospital Therapy named after               
V.G. Vogralik of the State Budget Higher Educational Institution “Nizhny Novgorod 
State Medical Academy” for scientific consultations; to Professor V.Y. Talaev, Doctor 
of Medicine, for joint investigations; and also to the researchers of the laboratories of 
cellular immunology and immunochemistry of the Federal Budget Science Institution 
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“Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology 
named after Academician I.N. Blokhina”. The author is grateful to all the employees of 
medical establishments and institutions who have taken part in conducting this 
investigation and applying its results. 
   
CONTENTS OF WORK 
MATERIALS AND METHODS 
Object of study 
The investigation was conducted from 2005 till 2013 and involved a checkup of 
children of different ages and adults, organized as well as unorganized ones. 1227 
children in Nizhny Novgorod and Nizhny Novgorod region, from 15 days old to 16 
years old, were examined; the patients had been previously diagnosed clinically and 
with X-ray as having CAP, acute bronchitis, bronchial asthma, and/or acute respiratory 
disease (ARD)/ acute respiratory viral infection (ARVI). The group of organized adults 
consisted in 469 patients of the 5
th
 Branch of Military Clinical Hospital #1586 of the 
Russian Ministry of Defense, the military personnel who had been previously diagnosed 
clinically and with X-ray as having CAP and/or acute bronchitis, and 145 unorganized 
adults, a heterogeneous group of patients from 25 to 60 years of age, undergoing either 
outpatient or in-patient treatment in hospitals of Nizhny Novgorod, diagnosed as having 
CAP and/or acute bronchitis. The screening group consisted of 127 practically healthy 
children of different age groups, 322 practically healthy adults, out of which 270 were 
(organized) recruits and 52 were (unorganized) people undergoing clinical examination. 
All the people from the screening group had no clinical symptoms of inflammatory 
respiratory diseases at the moment of examination nor within the previous month. 
The analyzed material was phlegm, oropharynx smears, blood, bronchoalveolar 
lavage; for infants younger than one year old – saliva, for healthy ones – oropharynx 
smears. The material was collected in accordance with methodological guidelines 
4.2.2039-05 “Technique of collecting and transporting biomaterials to microbiological 
laboratories” in procedure units of hospitals and polyclinics. 
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Molecular-genetic methods 
DNA was isolated out of biological substrates with the help of “DNK-sorb B” 
(“DNA-sorb B”) set of reagents. Samples of phlegm were first preconditioned with 
reagent “Mukolizin” (by the Federal Budget Institution of Science “Central Research 
Institute of Epidemiology” of The Federal Service on Customers’ Rights Protection and 
Human Well-being Surveillance). To isolate DNA out of a mix of substrates, different 
types of biological substrates from one patient were mixed in a disposable test-tube 1.5 
ml. in equal quantities so that the volume of the mix came up to 100 microliters. 
M. pneumoniae, Сytomegalovirus, Herpes simplex I/II were PCR-detected on test 
systems “AmpliSense” produced by the Federal Budget Institution of Science “Central 
Research Institute of Epidemiology” of The Federal Service on Customers' Rights 
Protection and Human Well-being Surveillance, according to the manual. Amplification 
was done on devices “Tertsic MS-2” (DNA technology, Moscow) or “My Cycler” (Bio-
Rad, the USA). 
C. pneumoniae, C. psittaci, L. pneumophila, M. catarrhalis were PCR-detected 
with reagents sets “GenPak DNA PCR test” produced by LLC “Isogen” (Moscow) 
according to the manual. Amplification was done on devices “Tertsic MS-2”. 
The sensitivity of test systems “AmpliSense” and “GenPak DNA PCR test” is no 
less than 1х103 – 5х103  bacterial cells or DNA-comprising viral parts per milliliter of 
clinical sample. 
Amplification products were detected by horizontal electrophoresis in 1.8% 
agarous gel with subsequent registration of the results with the help of ultraviolet 
transilluminator (“Biocom”, Russia) on the image processing system “Biotest-1” (by the 
Federal Budget Institution of Science “Central Research Institute of Epidemiology” of 
The Federal Service on Customers’ Rights Protection and Human Well-being 
Surveillance, Moscow). 
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Immunological investigation 
The immunological investigation was carried out jointly with the laboratories of 
biochemistry and cellular immunology of the Federal Budget Science Institution 
“Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology” 
named after Academician I.N. Blokhina, with the laboratories’ heads respectively V.V. 
Nemov, Candidate of Science in Biology, and Professor V.Y. Talaev, Doctor of 
Medicine. 119 military people were examined who had been previously diagnosed as 
having CAP (clinically and with X-ray), and different types of hard-to-cultivate 
pathogens causing respiratory diseases and herpes viruses were detected in their tests. 
The screening groups consisted of practically healthy adult donors (50 people) and 
healthy men of call-up age (50 people). The sick patients had their blood taken and 
tested thrice. 
The objects of study were indices of humoral immunity (the level of total 
immunoglobulins, lactoferrin, secretory (exocrine) immunoglobulin A, the level of 
circulating immune complexes). Immune-enzyme analysis and precipitation analysis 
were used, with the help of test-systems by the closed (joint-stock) company “Vector 
Best”. 
Cellular immunity was studied by measuring the distribution of cytokines in 
patients’ blood serum with the help of enzyme immunoassay, defining the functional 
state of T-cells and the quantity of interferon-producing T-cells after polyclonal 
activation of lymphocytes by estimating the intracellular cytokines with the help of laser 
flow cytometry. 
 
Statistic methods 
The data was processed with Microsoft Office (Excel) programs, the statistic 
program package Statz, Statistica 6.0. The reliability of the differences was stated by the 
generally accepted method of counting the standard error of mean (m) and indices of 
relevancy and probability (t). 
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RESULTS OF INVESTIGATION AND THEIR DISCUSSION 
In order to determine the most informative biological substratum (or their mix) 
for defining M. pneumoniae, C. pneumoniae, C. psittaci, L. pneumophila, M. 
catarrhalis, СMV, HSV I/II, the author analyzed the results of detecting these pathogens 
in samples from 176 organized adult patients with CAP. Both samples of a single type 
substratum and their mixtures in different combinations were examined. Also samples 
of bronchoalveolar lavage from 19 military people were analyzed separately. 
It was stated that most often pathogens causing the infections were found in 
phlegm: in 52.8±3.8 % cases (Figure 1). In oropharynx smears the pathogens were 
found positively (validly) less often: in 41.9±3.7 % cases (р<0.05). In blood samples, in 
single instances herpes viruses were found, and no pathogens causing bacterial 
infections were detected in blood. 
 
  
Figure 1. Contamination of different biological substrates with hard-to-cultivate 
pathogens causing respiratory diseases. 
1.2 – blood 
41.9 – oropharynx smears 
52.8 – phlegm 
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42.1 – bronchoalveolar lavage 
64.2 – a mixture of substrates 
 
It was established that in the mixture of phlegm and oropharynx smear the 
percentage of detected pathogens was positively (validly) higher and came up to 
64.2±3.6 % (р<0.05). In bronchoalveolar lavage samples (n=19) hard-to-cultivate 
pathogens were found in 42.1 % of cases. 
Consequently, it was established that investigating a mixture of several clinical 
substrates (phlegm, oropharynx smear, bronchoalveolar lavage) for a spectrum of the 
sought pathogens lowers the possibility of false-negative results by 18-35 % in 
comparison with analyzing only one type of substratum. 
Based on the data from literary sources and the results of the author’s own 
independent research, a spectrum of pathogens causing respiratory diseases was 
defined; the frequency of finding them, as a rule, was not higher than 5%: for adults 
these are C. psittaci, C. pneumoniae, L. pneumophila, M. сatarrhalis, CMV; for children 
C. pneumoniae, C. psittaci, L. pneumophila, M. сatarrhalis. PCR-based analysis for 
every kind of biological substratum from one and the same patient for 4 to 5 infectious 
agents according to the traditional scheme appears to be a very expensive method of 
investigation. To solve this problem the author suggests a new medical technology FS # 
2009/084, based on medical patent # 2406088. The essence of this method is detection 
of scarce pathogens (appearing in less than 5 % cases) in a DNA pool isolated from a 
substrates mixture (phlegm, smears from tunica mucosa of mouth, bronchoalveolar 
fluid) from five patients. 
In order to check the sensitivity of the “double minipools” method, comparative 
investigation of 50 DNA samples was carried out. The DNA was isolated from a 
substrates mixture with the known content as to infectious agents. PCR-based analysis 
of the samples as “double minipools” and also individual PCR-based analysis for every 
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single sample were performed. In order to get the infectious agent’s DNA maximally 
diluted, every pool consisted of one positive and four negative samples. The results 
acquired by the “double minipools” method and the results acquired by the individual 
sample analysis coincided in 100 % cases. It was shown that the dilution while pooling 
five samples has no influence on the effectiveness of revealing an infectious agent. The 
analysis of a substrates mixture took 1.5-2 times less time than a comprehensive 
analysis of a single substratum for every infectious agent. 
To substantiate the economic effect of using the “double minipools” method, the 
author carried out a PCR-based research of samples from 100 adult patients with CAP 
for four infections pathogens: CMV, C. psittaci, L. pneumophila, M. catarrhalis by the 
comprehensive method and by the “double minipool” method. 20 minipools of the 
substrates from five people each were formed, and a mixture of 2 substrates from every 
patient was analyzed. 
The “double minipools” method required 105 PCR-based analyses. Yet a 
comprehensive study of every substratum from each patient for four infections 
pathogens would require 800 PCR-based analyses; a study of a substrates mixture 
without pooling would require 400 PCR-based analyses. Accordingly, the usage of the 
“double minipools” method allows to lower the cost of investigation by 3.8–7.6 times. 
The investigation made it possible to estimate the frequency of detecting            
М. pneumoniae, C. pneumoniae, C. psittaci, L. pneumophila, M. catarrhalis, СMV,   
HSV I/II in patients suffering from inflammatory respiratory diseases. 
In Nizhny Novgorod region, bacterial hard-to-cultivate pathogens in infants under 
one year of age suffering from respiratory diseases were detected extremely seldom. 
Only two cases of detecting such pathogens were registered: М. Pneumoniae in a 11-
month-old child suffering from acute bronchitis and C. рsittaci in a 2-month-old child 
suffering from pleuropneumonia. 
М. pneumoniae appeared to be the most frequent pathogen for children from 1 to 
16 years of age having a respiratory pathology; the frequency of detecting it varied 
significantly (from 3.6 to 50%) depending on the nosologic form and the age of the 
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examined patients (Figure 2). The highest value of this characteristics (50.5±4.7 %) was 
positively registered in children from 7 to 16 years of age suffering from CAP 
(p<0.001).  
    
 
Figure 2. Frequency of detecting M. pneumoniae in children of different age groups 
with respiratory diseases. 
ВП – community-acquired pneumonia (CAP) 
ОБ – acute bronchitis 
ОРЗ/ОРВИ – acute respiratory disease (ARD) / acute respiratory viral infection (ARVI) 
БА – bronchial asthma 
 
BLUE – 0-1 year of age 
RED – 1-7 years of age 
GREEN – 7-16 years of age 
 
Note: * – the difference from the group of children 1-7 years of age is relevant and valid 
with р<0.001; 
** – the difference from the group of children 1-7 years of age is relevant and valid with 
р<0.01. 
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М. pneumoniae also prevailed in children with acute bronchitis, ARD / ARVI, 
bronchial asthma in age groups 1-7 y.o. and 7-16 y.o. In children suffering from acute 
bronchitis the frequency of detecting it came to 6.4 % and 20.5 % respectively (p<0.01); 
for those suffering from ARD / ARVI 3.6 % and 7.8 %; for those suffering from 
bronchial asthma – 5.7 % and 7.5 % respectively.  
Other bacterial pathogens (C. pneumoniae, C. psittaci, M. catarrhalis) in children 
with bronchopulmonary pathology were detected quite seldom. C.pneumoniae was 
detected in samples from children of 7-16 years of age suffering from CAP in      
3.6±1.8 % cases. In children suffering from acute bronchitis the pathogen was found in 
single instances in age groups of 1-7 years of age and 7-16 years of age. 
The highest result for the frequency of detecting C. psittaci (4.0±1.4 % in 1-7 years 
of age group and 3.6±2.0 % in 7-16 years of age group) was achieved for children 
suffering from acute bronchitis; during other nosologic forms of respiratory diseases 
this microorganism was found but in single instances. 
M.catarrhalis was detected but in single instances and only in children suffering 
from bronchitis in 1-7 years of age group and in 7-16 years of age group. 
L. pneumophila was not found in any form of pathology in any children’s age 
group. 
In the screening group hard-to-cultivate bacterial microorganisms were 
practically not found. This data shows that a wide circulation of “atypical” bacterial 
pathogens is not characteristic of Nizhny Novgorod region. 
The results of the investigation showed a high frequency of DNA replication for 
herpes viruses in children with any nosologic form. For example, CMV was found in 
children suffering from CAP in 34.9±2.6 % cases, in children suffering from acute 
bronchitis in 51.9±2.6 % cases, in children suffering from ARD / ARVI in 49.0±2.5 % 
cases, and in children suffering from bronchial asthma in 40.0±4.1 % cases (Figure 3). 
In healthy children CMV was detected less often by 2.5-3.5 times (p<0.001).  
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Figure 3. Frequency of finding CMV in children of different age groups with 
inflammatory respiratory diseases.  
ВП – community-acquired pneumonia (CAP) 
ОБ – acute bronchitis 
ОРЗ/ОРВИ – acute respiratory disease (ARD) / acute respiratory viral infection (ARVI) 
БА – bronchial asthma 
Контрольная группа – screening group 
 
Note: * – the difference from the screening group is relevant and valid with р<0.001; 
** – the differences are relevant and valid between the group of children suffering from 
acute bronchitis and groups of children with bronchial asthma (p<0.05), CAP,  
screening group (р<0.001); 
*** – the differences are relevant and valid between the group of children suffering 
from ARD / ARVI and groups of children suffering from CAP, screening group 
(р<0.001). 
 
The indices of detecting CMV were high enough in infants under one year of age, 
they came up to 26.2±3.9 % in children suffering from CAP; 44.0±5.7 % in children 
suffering from acute bronchitis; 56.2±5.8 % in children suffering from ARD / ARVI 
(Figure 4). 
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Most often CMV appeared to be detected in children from 1 to 7 years of age. In 
children suffering from CAP the virus was found in 56.7±4.9 % cases; in children 
suffering from acute bronchitis in 64.4±3.4 % cases; in children suffering from ARD / 
ARVI in 51.8±3.2% cases; in children suffering from bronchial asthma in 50.6±5.4 % 
cases (p<0.001). Only in children under 1 year of age and between 1 and 7 years of age 
suffering from ARD / ARVI the difference in the frequency of detecting CMV appears 
unreliable (not valid). 
 
Figure 4. Frequency of detecting the CMV DNA replication in children of different age 
groups having various respiratory diseases. 
ВП – community-acquired pneumonia (CAP) 
ОБ – acute bronchitis 
ОРЗ/ОРВИ – acute respiratory disease (ARD) / acute respiratory viral infection (ARVI) 
БА – bronchial asthma 
 
BLUE – 0-1 year of age 
RED – 1-7 years of age 
GREEN – 7-16 years of age 
Note: *– the differences between the group of children under 1 and in group 7-16 are 
relevant and valid with p<0.001; 
* 
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**– the differences between the group of children under 1 with CAP and groups of 
children under 1 with acute bronchitis and ARD /ARVI (р<0.01 and p<0.001, 
respectively). 
For the group of children from 7 to 16 the indices of detecting CMV were validly 
lower and came up to 24.3±4.0 % with CAP; 28.9±5.0 % with acute bronchitis; 
29.7±5.7 % with ARD / ARVI and 22.6±5.7% with bronchial asthma (p<0.001). 
The indices of detecting HSV I/II in children suffering from CAP (6.7±1.4 %) and 
those suffering from ARD / ARVI (5.2±1.1 %) were higher than in the screening group 
(p<0.01 and p<0.05, respectively). There has been found no valid difference in the 
frequency of detecting HSV I/II in healthy children and children with bronchial asthma 
and those with acute bronchitis. 
HSV I/II was more often detected in children from 7 to 16 years of age in all 
nosologic forms: if they had CAP – in 10.8±2.9 % cases, if they had acute bronchitis – 
in 9.6±3.2 %, if they had ARD / ARVI – in 7.8±3.6 % cases, if they had bronchial 
asthma – in 3.8±2.6 % cases (Figure 5). 
 
Figure 5. Frequency of detecting HSVI/II DNA in children of different age groups 
having various forms of respiratory diseases. 
ВП – community-acquired pneumonia (CAP) 
ОБ – acute bronchitis 
ОРЗ/ОРВИ – acute respiratory disease (ARD) / acute respiratory viral infection (ARVI) 
БА – bronchial asthma 
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BROWN – 0-1 years of age 
YELLOW – 1-7 years of age 
GREEN – 7-16 years of age 
Note: * – the difference with the group of children from 7 to 16 is relevant and valid 
with p<0.05. 
 
Since the majority of the examined adults, both unorganized and organized, were 
diagnosed with CAP, and the number of patients having acute bronchitis was minor, the 
author found it expedient to analyze them as one group, especially because the 
frequency of detecting the pathogens causing these two types of infections showed no 
statistically relevant difference. In Table 1 one can find the data on the frequency of 
detecting pathogens causing various infections in adults suffering from inflammatory 
respiratory diseases. 
Table 1. 
Frequency of Detecting Hard-to-Cultivate Pathogens in Adults (M±m(%)). 
 
Pathogen 
 
organized unorganized 
patients 
(n=469) 
screening 
(n=270) 
patients  
(n=145) 
screening 
 (n=52) 
M. pneumoniae 9.8±1.4 0 2.8±1.4 0 
C. pneumoniae 10.4±1.4 0 1.4±1.0 0 
C. psittaci  0.2±0.2 0 0 0 
L. pneumophila 0.6±0.4 0 0 0 
M. catarrhalis 1.7±0.6 1.1±0.6 2.1±1.2 1.9±1.9 
CMV  5.1±1.0 4.1±1.2 3.5±1.5 3.8±2.7 
HSV I/II 15.4±1.6 3.3±1.0 10.3±2.5 1.9±1.9 
 
As one can infer from Table 1, M. pneumoniaе and C. pneumoniaе in organized 
adult patients were found in 9.8 % and 10.4 % cases respectively, whereas in the 
screening group these pathogens were not detected. 
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The frequency of detecting these pathogens in the group of unorganized adults 
was validly lower and came up to 2.8 % and 1.4 % respectively (p<0.001). In both 
groups of patients the frequency of detecting HSV I/II was high as compared to the 
screening groups (p<0.01). With the military personnel the index was 15.4 %, with 
unorganized adults 10.3 %, and statistically these two indices did not differ.                  
L. рneumophila was detected only in samples from three military people. C. psittaci was 
found but in one military person who had CAP. It was not found in unorganized adult 
patients. The frequency of detecting M. catarrhalis in organized and unorganized 
patients showed no statistical difference and came up to 1.7 % and 2.1 % respectively. 
The immunologic investigation showed that the called-up military people who 
suffered from CAP had “immunologic deficiency”. For example, estimation of the level 
of cytokines in the patients’ blood serum indicates relative weakness of the cellular 
immune reaction when CAP developed. At the moment of hospitalization, i.e. at the 
peak of the inflammatory process development, the patients’ tests displayed no 
significant growth of cytokines produced by T helper cells of the first type, 
proinflammatory regulators of interferon-γ and tumor necrosis factor-α (Table 2). The 
concentration of such cytokines exceeded the average for healthy people but by 1.3 and 
1.6 times, respectively, at that the maximal concentration of cytokines in 98 % of the 
patients did not exceed 40 pcg/ml and 4 pcg/ml, respectively. The interferon-α 
concentration in those suffering from CAP did not validly exceed the average for 
healthy people, either. The mean concentration was 7.4 pcg/ml, and 65.5 % patients’ 
tests showed no interferon-α in blood serum.  
25 
 
 
 
Table 2. 
Level of Cytokines During Inflammation in 
Blood Serum of Patients Suffering from Community-Acquired Pneumonia 
  
Cytokines Concentration of cytokines (pcg/ml) in blood serum 
Patients with pneumonia 
(n=100) 
Healthy donors (n=50) 
Interferon- α 4.41±1.03 4.31±1.05 
Interferon –γ 32.31±4.25 24.8±6.3 
Tumor necrosis factor -α 3.62±0.13 3.02±0.31 
Interleukin-8 52.14±7.83* 25.9±4.67 
Interleukin 1 receptor 
antagonist  
1039.57±123.8* 232.45±54.1 
Note. * –  the difference from the average of the screening group of healthy donors is 
relevant and valid with p<0.05. 
 
The average concentration of interleikin-8 in military patients suffering from 
CAP validly exceeded the concentration of this cytokine for healthy donors. However, 
its concentration in samples from the majority of the examined patients with pneumonia 
(58.9 %) did not exceed 30 pcg/ml which is the top of the norm for interleikin-8 in 
healthy adults. 
The most informative parameters appeared to be the ones showing the functional 
state of the immune system cells, particularly T-lymphocytes. The author studied the 
capability of T-lymphocytes to produce interferon-γ, not by estimating the number of T-
cells producing this kind of cytokine during the illness but by analyzing the potential 
capability of the immune system to fulfill this function. It was shown that the number of 
T-lymphocytes that can produce interferon-γ in the examined military patients 
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hospitalized with CAP was considerably lower than in the screening group of practically 
healthy donors. 
The average number of T-cells that produce interferon when they get activated 
was for patients with pneumonia, at the beginning of their disease period, 16.24±2.15%, 
and for healthy donors this index came up to 29.25±3.5% (р<0.001). The fact that this 
functional deficiency was detected means it would be sensible to take some action in 
order to support the immune system, to compensate for the deficiency of the produced 
interferons during pneumonia. In this light, it is not expedient to use inductors of 
interferon production when treating CAP, and it is more appropriate to use substitutive 
therapy with interferon preparations. It is shown that the analysis of the circulating 
immune complexes levels has high prognostic value for patients with CAP. The average 
level of high-molecular circulating immune complexes in sick people’s samples came 
up to 68±13.5 standard units, the level of low-molecular circulating immune complexes 
was 149±13 standard units. The ratio between low-molecular circulating immune 
complexes and high-molecular circulating immune complexes (the so-called relative 
coefficient) varies within the range of 0.3-23.4, which can testify to a high diagnostic 
value of this index during inflammatory destructive processes in the lungs. When the 
disease progressed and its clinical course was aggravating, the number of circulating 
immune complexes was lowering, and the relative coefficient of the circulating immune 
complexes was growing. For example, for groups with a light clinical course of 
pneumonia the level of high-molecular circulating immune complexes came up to 360 
standard units, and the lowest index of the relative coefficient of the circulating immune 
complexes was 0.34. For those with a more serious state, the level came up to 120 
standard units, and the lowest index of the relative coefficient of the circulating immune 
complexes was 1.1. The most serious clinical course of CAP was accompanied with a 
paradoxical effect of the decline in the circulating immune complexes level, which is 
explained by the decline in the immunocompetence of the humoral immunity unit. The 
level of the circulating immune complexes was the lowest in this group (74 standard 
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units), and the lowest index of the relative coefficient of the circulating immune 
complexes was 2.03. 
The analysis of the frequency of detecting M. pneumoniae, C. pneumoniae, C. 
psittaci, L. pneumophila, M. catarrhalis, СMV, HSV I/II allowed to elaborate an 
algorithm of PCR-based detection of these pathogens for an initial screening in children 
and adults suffering from respiratory diseases. The investigation is based on analyzing 
phlegm, bronchoalveolar lavage, oropharynx smears; for infants under one year of age 
one can use saliva. The first step is to isolate DNA out of a mixture of various 
biological substrates from one and the same patient. The substrates are mixed in equal 
proportions so that the total volume comes up to 100 microliters, which is the 
recommended volume for isolating DNA with the help of reagents set “DNK-sorb B” 
(“DNA-sorb B”) (by the Federal Budget Institution of Science “Central Research 
Institute of Epidemiology” of The Federal Service on Customers’ Rights Protection and 
Human Well-being Surveillance). Further, PCR-based investigation is carried out in 
order to detect pathogens that tend to appear more often than in 5% of samples: for 
infants under 1 year of age CMV; for children from 1 to 7 M.pneumoniae, CMV, HSV 
I/II; for children from 7 to 16 M.pneumoniae, CMV, HSV I/II (Figure 4); for 
unorganized adults HSV I/II. For detecting СMV, HSV I/II, M. pneumoniae with the help 
of PCR, test-systems of “AmpliSense” series (by the Federal Budget Institution of 
Science “Central Research Institute of Epidemiology” of The Federal Service on 
Customers' Rights Protection and Human Well-being Surveillance) were used, 
according to the manual. For PCR-based detection of C. pneumoniae, C. psittaci, L. 
pneumophila, M. catarrhalis, “GenPak DNA PCR test” reagents sets were used, 
produced by LLC “Isogen” (Moscow). Amplification was done on devices “Tertsic MS-
2” (DNA technology, Moscow) or “My Cycler” (Bio-Rad, the USA). 
For detecting scarce pathogens causing inflammatory respiratory diseases with 
the help of PCR, a minipool of DNA preparations is formed, the preparations being 
isolated out of a mixture of substrates from five (four, three) patients. The DNA 
preparations are mixed in equal proportions so that the mixture volume for one PCR-
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based analysis comes up to 10 microliters (2 microliters from 5 people, or 2.5 
microliters from 4 people, or 3.3 microliters from 3 people). Amplification products 
were detected by horizontal electrophoresis in 1.8% agarous gel. If one or several 
pathogens are found in the minipool, every component of the pool gets analyzed. The 
same test-systems and electrophoresis are used as methods of detecting the PCR 
products. An example of this algorithm is shown in Figure 6. 
  
Figure 6. Algorithm of detecting hard-to-cultivate pathogens causing respiratory 
diseases in children from 1 to 6 years of age with the help of PCR. 
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This method has been instilled in the work of the laboratory for metagenomics and 
indicating pathogens and Volga-Vyatka Regional Academic and Research Center for 
Indication, Identification and Taxonomy of Microorganisms and Organization of Anti-
Epidemic work in Extreme Conditions of the Federal Budget Science Institution 
“Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology 
named after Academician I.N. Blokhina” of the Federal Directorate for Consumer 
Rights and Health Protection. 
The method of “double minipools” is effective in detecting the following 
infectious agents: for infants under 1 year of age: M.pneumoniae, HSV I/II типов, 
C.psittaci, C.pneumoniae, L.pneumophila, M.catarrhalis; for children from 1 to 7 years 
of age: C.pneumoniae, C.psittaci, L.pneumophila, M.catarrhalis; for children from 7 to 
16: C.pneumoniae, C.psittaci, L.pneumophila, M.catarrhalis; for unorganized adults: 
M.pneumoniae, C.pneumoniae, C. psittaci, L. pneumophila, M. catarrhalis, CMV; for 
organized adults: C.psittaci, L.pneumophila, M.catarrhalis. 
 
CONCLUSION 
The experiments that have been conducted give the author the opportunity to formulate 
the following conclusions. 
1. The author has optimized the method of detecting hard-to-cultivate 
microorganisms, i.e. pathogens causing respiratory diseases, with the help of PCR. The 
method is based on pooling mixtures of substrates from 3 to 5 patients (“double 
minipools”) and allows to make a low-costing screening of patients suffering from 
different types of respiratory pathology and to cut the time of diagnostic investigation 
by 1.5-2 times. 
2. It is proved that the most informative substrates for PCR-based detection of hard-
to-cultivate microorganisms causing respiratory infections are phlegm (the infectious 
agent gets detected in 52.8 % samples) and smears from the posterior pharyngeal wall 
(41.9 % results are positive). Examining a mixture of these substrates allows to raise the 
frequency of detecting pathogens by 18-35%. 
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3. The author registers a high frequency of detecting M. pneumoniae in children 
from 7 to 16 years of age suffering from CAP and acute bronchitis (50.5% and 20.5% 
respectively). At the same time, she registers a low frequency of detecting C. psittaci, L. 
pneumophila, M. catarrhalis in Nizhny Novgorod region for children and adults (both 
organized and unorganized) with bronchopulmonary pathologies. 
4. The investigation results display an active replication of herpes viruses in 
children of different ages. The highest frequency of detecting CMV (50.6% – 64.4%) 
have been registered in samples taken from children from 1 month old to 7 years old, 
HSV I/II (7.8% – 10.8%) – in children from 7 to 16 notwithstanding the nosologic form 
of the prevailing disease. 
5. It is revealed that for adults in organized collectives the leading types of hard-to-
cultivate pathogens causing respiratory diseases are M. pneumoniae (9.8%) and           
C. pneumoniae (10.4%). For unorganized adults these pathogens appear less often:     
M. pneumoniae – 2.8%, C. pneumoniae – 1.4%. The frequency of detecting HSV I/II 
was high for both organized and unorganized adults and came up to 15.4% and 10.3%, 
respectively, which validly exceeds this index in the screening group of practically 
healthy people. 
 
Practical Recommendations 
1. For epidemiological supervision of patients suffering from CAP and for 
elaboration of the medical and preventive measures it is sensible to take into 
consideration the properties of hard-to-cultivate infectious agents’ distribution peculiar 
to the specific region. 
2. Since some types of hard-to-cultivate microorganisms associated with respiratory 
diseases are widespread, it is necessary to give patients a complex PCR-based 
examination. 
3. The suggested algorithm of PCR-based detection of hard-to-cultivate pathogens 
causing respiratory diseases is recommended for a low-costing screening of patients 
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suffering from different types of respiratory pathology as it allows to cut the cost and 
the length of the diagnostic investigation. 
4. Since the examined military personnel with CAP displayed deficiencies in the 
immune system work, it is advisable for such patients to have a full checkup of the 
immune system and, if necessary, to undergo a course of treatment correcting the 
immunity and compensating for the interferon production deficiency.  
 
Prospects and Directions for Further Work in this Field  
Several prospects are to be named. The first task is monitoring of the distribution 
of hard-to-cultivate pathogens causing respiratory diseases, on the basis of the 
suggested algorithm with the help of PCR. The second task is to broaden the specter of 
infectious agents that can be analyzed on the basis of the “double minipools” method in 
molecular diagnostics for respiratory diseases. The third prospect is studying the genetic 
variability and antibiotic resistance of hard-to-cultivate infectious agents on the basis of 
the highly productive sequencing technology that allows for analyzing the circulating 
populations of pathogens causing respiratory diseases, in more detail. 
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CAP – community-acquired pneumonia 
PCR – polymerase chain reaction 
ARD – acute respiratory disease  
ARVI – acute respiratory viral infection 
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